Akebia Therapeutics Inc. (AKBA) Fell -5.92% or -0.8 To Price $12.72 On Tuesday

Akebia Therapeutics Inc. (AKBA) fell -5.92% or -0.8 to $12.72. It is nearly 429516 shares traded, which is 129.08% compare to the average total volume 332759. The market cap of AKBA is $601.26 million. The year to date change is -9.69%. The 52 week price range is from $8.69 to $20.25. Price of AKBA have changed -4.79% during last week. It have changed -6.44% over last month, -11.69% over last 3 months, -20.70% over last 6 months and 45.22% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKBA is 14.77. It is 16.12% above current price. The 200-day Moving Averages for AKBA is 15.47. It is 21.62% above current price. The 52-week High is 20.25. It is 59.20% from the current price. The 52-week Low is 8.69. It is -31.68% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of AKBA is 12.88 on 2018-02-28. Short % to float is 7.87%. There are some statistics of AKBA. It is has market cap $601.26 million. The share outstanding is 47.27 million. The average volume is 332759. The revenue is 92.20M. The percent of top 15 Institution holding is 39.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKBA is -126.69%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKBA is -50.05%.


Share this post